Steven Rosenberg - PDFSEARCH.IO - Document Search Engine

Steven Rosenberg
Results: 16

#	Item
1	restifo-CD8_TcellDiff_v02 Add to Reading List Source URL: home.ccr.cancer.gov Language: English - Date: 2012-02-01 13:39:40 National Institutes of Health Cancer research Oncologists James L. Gulley Fred Hutchinson Cancer Research Center NIH Intramural Research Program BRCA1 Steven Rosenberg Prostate cancer Medicine Oncology Cancer organizations
2	T Cell Immunotherapy - Optimizing Trial Design Office of Biotechnology Activities September 10, 2013 Overview Steven A. Rosenberg, M.D., Ph.D. Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-01-09 16:16:28 Immunology Cancer treatments Lymphoma Immunotherapy B-cell chronic lymphocytic leukemia Melanoma Cancer immunotherapy Chimeric antigen receptor Lymphocyte Medicine Immune system T cells
3	NATIONAL INSTITUTES OF HEALTH (NIH) SAFETY SYMPOSIUM GENE-MODIFIED T CELLS: CHALLENGES IN CLINICAL TRIAL DESIGN Hilton Rockville Hotel & Executive Center June 15, 2010 Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-03-19 16:40:37 Steven Rosenberg CD20 Immunoglobulin E Antigen Immune system Biology Chimeric antigen receptor
4	T Cell Immunotherapy - Optimizing Trial Design Office of Biotechnology Activities September 10, 2013 Host preparation Steven A. Rosenberg, M.D., Ph.D. Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-01-09 16:16:38 Radiobiology Cancer treatments Immunotherapy Steven Rosenberg Influenza Regulatory T cell Cyclophosphamide Radiation therapy Cell transfer therapy Medicine T cells Immunology
5	T Cell Immunotherapy - Optimizing Trial Design Office of Biotechnology Activities September 10, 2013 Target selection Steven A. Rosenberg, M.D., Ph.D. Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-01-09 16:17:27 Cancer treatments T cells Tumor markers Cancer immunotherapy Immunotherapy Carcinoembryonic antigen Cancer HLA-A Squamous-cell carcinoma Medicine Immunology Oncology
6	PDF Document Add to Reading List Source URL: home.ccr.cancer.gov Language: English - Date: 2014-07-08 18:13:53 Melanoma Immunotherapy Medicine Oncologists Steven Rosenberg
7	T Cell Immunotherapy - Optimizing Trial Design Office of Biotechnology Activities September 10, 2013 Overview Steven A. Rosenberg, M.D., Ph.D. Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-01-13 09:37:02 Immunology Cancer treatments Lymphoma Immunotherapy B-cell chronic lymphocytic leukemia Melanoma Cancer immunotherapy Chimeric antigen receptor Lymphocyte Medicine Immune system T cells
8	T Cell Immunotherapy - Optimizing Trial Design Office of Biotechnology Activities September 10, 2013 Host preparation Steven A. Rosenberg, M.D., Ph.D. Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-01-13 09:41:36 Radiobiology Cancer treatments Immunotherapy Steven Rosenberg Influenza Regulatory T cell Cyclophosphamide Radiation therapy Cell transfer therapy Medicine T cells Immunology
9	T Cell Immunotherapy - Optimizing Trial Design Office of Biotechnology Activities September 10, 2013 Target selection Steven A. Rosenberg, M.D., Ph.D. Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-01-13 09:46:53 Cancer treatments T cells Tumor markers Cancer immunotherapy Immunotherapy Carcinoembryonic antigen Cancer HLA-A Squamous-cell carcinoma Medicine Immunology Oncology
10	T Cell Immunotherapy – Optimizing Trial Design Office of Biotechnology Activities Office of Science Policy National Institutes of Health (NIH) Bethesda, MD September 10-11, 2013 Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-03-19 16:23:39 Chimeric antigen receptor Fred Hutchinson Cancer Research Center Steven Rosenberg Cancer immunotherapy Cancer research Medicine Cancer organizations Immune system

UPDATE